Pharmacology & ToxicologybioRxivPreprint
Intraventricular infusion to circumvent the blood-brain barrier to gemcitabine.
Bruno Chauffert, Antoine Galmiche, Christophe Louandre…·Jacques Beaurain
This study demonstrates that intraventricular infusion of gemcitabine bypasses the blood-brain barrier in preclinical models, achieving therapeutic concentrations in brain tissue.
DOI 10.64898/2026.05.01.722145